Biocodex invests €15 million in Beauvais
Published
The pharmaceutical laboratory Biocodex announced, on 5 November 2026, an investment of €15 million at its Beauvais site, in the Oise department. This significant sum shows the company's determination to develop its activities in this city in northern France.
According to the information published, this investment concerns the Beauvais industrial site. It will make it possible to modernise the facilities and strengthen production on site. For the residents of the Oise, this decision is good news, as it may help to maintain employment in the region.
Biocodex is a French company well known in the health sector. It has a presence in several countries, but its Beauvais site remains an important part of its activity in France. The precise details of the work schedule and the number of jobs concerned have not yet been communicated in the information available.
In conclusion, this €15 million investment project confirms the attractiveness of the Beauvais site. It also illustrates the importance of the pharmaceutical industry for the local economy. The next stages of the project will be followed with interest by employees and local elected officials in the region.
Sources: L'Usine Nouvelle
More France news
- Maxime Pavageau, 29, wins France's best young wine seller title
- A New, Highly Promising Concrete
- Paris and Île-de-France: Immersive Exhibitions to Experience Art Differently
- France 3 broadcasts a documentary on the history of the Téléthon, narrated by Zazie
- ChatGPT launches business profiles with mention and click statistics
- Trail: France Outdoor Seeks to Frame Environmental Restrictions
- A Roanne company bets on knitwear made in France
- Sport: Major Win for the Brûleurs de Loups and Six Internationals Absent for FC Annecy